Phlegmonous Gastritis

Comprehensive Clinical Guide: Phlegmonous Gastritis

1. Introduction and Overview

Phlegmonous gastritis (PG) is an exceedingly rare, life-threatening, and fulminant bacterial infection of the gastric wall. Unlike common forms of gastritis, which typically involve superficial mucosal inflammation, PG is characterized by a suppurative, purulent infiltration of the submucosal layer, often extending into the muscularis propria and serosa. Due to its rapid progression and high mortality rate—historically exceeding 50%—it is considered a surgical and medical emergency requiring immediate recognition and aggressive intervention.

The term "phlegmonous" refers to the diffuse, spreading nature of the inflammation within the connective tissue planes. Because the stomach is a highly vascularized organ with a robust mucosal barrier, it is typically resistant to bacterial invasion. Therefore, the development of PG almost invariably suggests a significant underlying compromise of the host’s immune system or a breach in the gastric mucosal integrity.

2. Etiology and Pathophysiology

The Mechanisms of Infection

The pathogenesis of PG revolves around the disruption of the gastric mucosal barrier, allowing pathogenic organisms to colonize the submucosal space. Once the mucosal integrity is compromised, the loose connective tissue of the submucosa acts as an ideal medium for bacterial proliferation.

Common Causative Agents:
* Streptococcus species: (Specifically Streptococcus pyogenes and S. pneumoniae) remain the most frequent pathogens.
* Staphylococcus aureus: Often associated with secondary infections in immunocompromised individuals.
* Escherichia coli and Klebsiella: Frequently isolated in polymicrobial infections.
* Haemophilus influenzae and Clostridium species: Rare but reported in specific clinical settings.

Predisposing Factors

The pathophysiology follows a sequence: bacterial translocation across the mucosa leads to acute inflammation, causing edema, microabscess formation, and eventually, full-thickness wall necrosis. The lack of anatomical barriers within the gastric submucosa allows the infection to spread rapidly along the greater curvature, where the submucosal layer is most pronounced.

3. Clinical Presentation and Staging

Standard Clinical Presentation

Phlegmonous gastritis does not have a "classic" presentation, which often leads to delayed diagnosis. Patients typically present with a constellation of non-specific but severe symptoms:
1. Acute Epigastric Pain: Often described as severe, boring, and constant.
2. SIRS Response: High fever, rigors, tachycardia, and tachypnea.
3. Gastrointestinal Distress: Nausea, intractable vomiting (sometimes hematemesis), and abdominal distension.
4. Peritoneal Signs: Guarding, rebound tenderness, and rigidity indicating potential perforation or peritonitis.

Staging/Classification

While there is no universally accepted "staging" system like in oncology, clinicians often categorize PG into two clinical patterns:

• Localized (Circumscribed) Phlegmon: The infection is confined to a specific segment of the stomach, often associated with a localized ulcer or mass. This form carries a better prognosis if resected early.
• Diffuse (Infiltrative) Phlegmon: The infection involves the entire gastric wall, leading to severe wall thickening, rigid "leather bottle" (linitis plastica-like) appearance, and higher systemic toxicity.

4. Diagnostic Evaluation

Imaging Modalities

• Computed Tomography (CT) with Contrast: The gold standard. Key findings include diffuse or localized gastric wall thickening, submucosal edema (the "target sign"), and perigastric fat stranding. Gas bubbles within the wall (emphysematous gastritis) may indicate a progression to necrotizing infection.
• Endoscopy (EGD): Must be performed with caution due to the risk of perforation. Findings include thickened, erythematous, and friable mucosa, often with purulent exudate. Biopsy is essential for pathogen identification but carries a risk of iatrogenic rupture.

Laboratory Investigations

• CBC: Marked leukocytosis with a left shift.
• Inflammatory Markers: Significantly elevated C-reactive protein (CRP) and procalcitonin.
• Blood Cultures: Positive in approximately 50% of cases; vital for tailoring antibiotic therapy.
• Gastric Aspirate/Fluid Culture: If endoscopic drainage is performed, culture of the purulent material is the most accurate way to guide definitive antimicrobial treatment.

5. Differential Diagnosis

Distinguishing PG from other acute abdominal pathologies is critical:
* Peptic Ulcer Perforation: Usually presents with pneumoperitoneum on imaging.
* Acute Pancreatitis: Typically associated with elevated lipase/amylase and specific imaging findings.
* Gastric Adenocarcinoma: Can mimic the wall thickening of PG; biopsy is required for differentiation.
* Corrosive Gastritis: History of chemical ingestion is usually clear.
* Emphysematous Gastritis: A subset of PG characterized by gas-forming organisms; requires immediate surgical consultation.

6. Treatment Strategies

Medical Management

Initial treatment must be aggressive and empiric.
1. Resuscitation: IV fluids and hemodynamic stabilization.
2. Broad-Spectrum Antibiotics: Immediate administration of intravenous antibiotics covering Gram-positive, Gram-negative, and anaerobic organisms (e.g., Carbapenems or a combination of Piperacillin-Tazobactam plus Vancomycin).
3. Nutritional Support: Total Parenteral Nutrition (TPN) is often required as the stomach is non-functional.

Surgical Management

Surgery remains the cornerstone of treatment, particularly when there is evidence of perforation, abscess formation, or failure to respond to medical management.
* Debridement/Drainage: In localized cases, simple drainage may suffice.
* Gastrectomy: For diffuse involvement or necrotic tissue, partial or total gastrectomy is the life-saving standard of care.

7. Risks, Contraindications, and Prognosis

Risks of Intervention:
* Endoscopy: High risk of perforation due to the friability of the gastric wall.
* Surgery: High morbidity due to the patient’s underlying compromised state (e.g., poor wound healing, sepsis).

Prognosis:
The prognosis is guarded. Mortality ranges from 25% to 60% depending on the speed of diagnosis. Long-term survivors of total gastrectomy face nutritional challenges, requiring lifelong B12 supplementation and iron monitoring.

8. Frequently Asked Questions (FAQ)

1. Is Phlegmonous Gastritis the same as Emphysematous Gastritis?
No. Emphysematous gastritis is a specific, more severe form of phlegmonous gastritis characterized by the presence of gas within the gastric wall, typically caused by gas-forming organisms.

2. Why is the mortality rate so high?
The high mortality is due to the non-specific symptoms that delay diagnosis, the rapid systemic spread of sepsis, and the surgical challenges of operating on an inflamed, friable, and infected gastric wall.

3. Can Phlegmonous Gastritis be cured with antibiotics alone?
While some early, localized cases have been managed with antibiotics alone, the standard of care usually involves surgical intervention, especially if the patient shows signs of peritonitis or systemic toxicity.

4. What is the most common pathogen?
Streptococcal species, particularly Streptococcus pyogenes, are the most frequently identified culprits.

5. How is it diagnosed definitively?
Definitive diagnosis is reached through a combination of contrast-enhanced CT scanning and bacterial culture of the gastric exudate.

6. Does the patient need a gastrectomy?
A gastrectomy is often necessary if the infection has caused irreversible necrosis or if the patient fails to stabilize on medical therapy.

7. Is this contagious?
No, it is an opportunistic infection resulting from a breach in the host's natural defenses, not a communicable disease.

8. What role does endoscopy play?
Endoscopy is diagnostic, but it is high-risk. It should only be performed by experienced endoscopists in a controlled environment, keeping the risk of perforation in mind.

9. Can it happen to healthy people?
It is extremely rare in healthy individuals. It almost always occurs in patients with pre-existing gastric disease, immune suppression, or malnutrition.

10. What are the long-term nutritional consequences?
If a partial or total gastrectomy is performed, patients may struggle with "dumping syndrome," vitamin deficiencies (B12, Iron, Calcium), and significant weight loss, requiring lifelong dietary management.

9. Conclusion

Phlegmonous gastritis is a rare but lethal clinical entity that demands a high index of clinical suspicion. Its rapid progression requires a multidisciplinary approach involving infectious disease specialists, gastroenterologists, and surgeons. Early recognition, aggressive hemodynamic support, prompt antibiotic initiation, and timely surgical intervention are the only avenues to improve patient outcomes in this challenging medical condition.